Showing results (91-100 of 126) with videos related to

Sort By:
Pageof 13
The Journal of Experimental Medicine|March 23, 2005
Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosisAmir Abdollahi, Minglun Li, Gong Ping, et al.
Physics in Medicine and Biology|October 15, 2019
CBCT correction using a cycle-consistent generative adversarial network and unpaired training to enable photon and proton dose calculationChristopher Kurz, Matteo Maspero, Mark H F Savenije, et al.
The Canadian Journal of Urology|March 9, 2026
Artificial intelligence in urological malignancy diagnosis and prognosis: current status and future prospectsMingwei Zhan, Zhaokai Zhou, Jianpeng Zhang, et al.
European Journal of Haematology|March 11, 2022
Primary radiation therapy in stage I/II indolent orbital lymphoma - a comprehensive retrospective recurrence and toxicity analysisChukwuka Eze, Isabelle Friedrich, Indrawati Hadi, et al.
Radiation Oncology (London, England)|March 4, 2018
Outcome after PSMA PET/CT based radiotherapy in patients with biochemical persistence or recurrence after radical prostatectomyNina-Sophie Schmidt-Hegemann, Wolfgang Peter Fendler, Harun Ilhan, et al.
Frontiers in Pharmacology|December 16, 2022
Adjuvant effects of Chinese medicinal tonics on gastric, liver, and colorectal cancers-OMICs-based contributions to understanding their mechanism of actionZhigang Zuo, Jia Jia, Hongliang Li, et al.
EJNMMI Research|June 23, 2026
Outcome after primary directed radiotherapy in predominantly PSMA-PET/CT-staged patients with metastatic prostate cancerChristian Trapp, Sarah Frederike Brose, Michael Keilholz, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 19, 2021
Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy ± immune checkpoint inhibitionMarcus Unterrainer, Julian Taugner, Lukas Käsmann, et al.
Clinical and Translational Radiation Oncology|January 6, 2023
Elective nodal radiotherapy with a gapless radiation field junction for oligorecurrent prostate cancer after previous radiotherapyMinglun Li, Yourong Fan, Christian Trapp, et al.
International Journal of Biological Macromolecules|March 26, 2025
Identification of CACNB1 protein as an actionable therapeutic target for hepatocellular carcinoma via metabolic dysfunction analysis in liver diseases: An integrated bioinformatics and machine learning approach for precise therapyJing Sun, Run Shi, Zhaokai Zhou, et al.
Pageof 13